News and Events
Company Profile
Vasudha Pharma Chem Limited was incorporated as a public limited company under the Companies Act, 1956 at Hyderabad in the state of Andhra Pradesh, India during the year 1994 - 95. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients ( APIs ), Pharma Intermediates for catering to the domestic as well as international market.
The company recognized the vital role of R & D for becoming successful in the generic market. Initially, the focus was on development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003 -04, the company gained world class expertise and became the largest manufacturers of piperidone & piperidine derivatives in the world. Subsequently, the company forward integrated from intermediates of piperidone & piperidine derivatives to APIs and later on diversified into large product portfolio of about 30 APIs spreading across several therapeutic areas.
With the strength of its portfolio, the gross sales of the company has grown from Rs 16.50 million ( US$ 0.36 million ) in 1997 -98 to Rs 2.36 billion ( US$ 51.30 million ) in 2008 - 09 ( considering 1 US$ = Rs 46.-- ). The composition of export sales to gross sales is mostly around 45% due to the importance given to the product quality, timely delivery and competitive pricing. The company has two manufacturing facilities.
First manufacturing facility at Jeedimetla, Hyderabad, Andhra Pradesh was set up in 1997 - 98 and subsequently upgraded to cGMP standards in 2006 - 07. Second manufacturing facility was set up in Jawaharlal Nehru Pharma City, Visakhapatnam District, Andhra Pradesh in 2007 - 08 with WHO GMP standards. The company has started the project implementation of its third manufacturing facility at Jawaharlal Nehru Pharma City, Visakhapatnam District with initial capital outlay of Rs 300 millions.
The company has already obtained WHO GMP certification for all its leading APIs and obtained COS for three of its APIs. The company has also filed DMFs with USFDA and EDQM for three of its APIs. The company has also file DMFs for its various products with European, Chinese, Japanese and Russian regulatory authorities.
The company recognized the vital role of R & D for becoming successful in the generic market. Initially, the focus was on development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003 -04, the company gained world class expertise and became the largest manufacturers of piperidone & piperidine derivatives in the world. Subsequently, the company forward integrated from intermediates of piperidone & piperidine derivatives to APIs and later on diversified into large product portfolio of about 30 APIs spreading across several therapeutic areas.
With the strength of its portfolio, the gross sales of the company has grown from Rs 16.50 million ( US$ 0.36 million ) in 1997 -98 to Rs 2.36 billion ( US$ 51.30 million ) in 2008 - 09 ( considering 1 US$ = Rs 46.-- ). The composition of export sales to gross sales is mostly around 45% due to the importance given to the product quality, timely delivery and competitive pricing. The company has two manufacturing facilities.
First manufacturing facility at Jeedimetla, Hyderabad, Andhra Pradesh was set up in 1997 - 98 and subsequently upgraded to cGMP standards in 2006 - 07. Second manufacturing facility was set up in Jawaharlal Nehru Pharma City, Visakhapatnam District, Andhra Pradesh in 2007 - 08 with WHO GMP standards. The company has started the project implementation of its third manufacturing facility at Jawaharlal Nehru Pharma City, Visakhapatnam District with initial capital outlay of Rs 300 millions.
The company has already obtained WHO GMP certification for all its leading APIs and obtained COS for three of its APIs. The company has also filed DMFs with USFDA and EDQM for three of its APIs. The company has also file DMFs for its various products with European, Chinese, Japanese and Russian regulatory authorities.
Copyright 2009-2010 Vasudha Pharma chem Limited.